175 related articles for article (PubMed ID: 21920013)
1. Functional factor VIII made with von Willebrand factor at high levels in transgenic milk.
Pipe SW; Miao H; Butler SP; Calcaterra J; Velander WH
J Thromb Haemost; 2011 Nov; 9(11):2235-42. PubMed ID: 21920013
[TBL] [Abstract][Full Text] [Related]
2. Transgenic pigs produce functional human factor VIII in milk.
Paleyanda RK; Velander WH; Lee TK; Scandella DH; Gwazdauskas FC; Knight JW; Hoyer LW; Drohan WN; Lubon H
Nat Biotechnol; 1997 Oct; 15(10):971-5. PubMed ID: 9335047
[TBL] [Abstract][Full Text] [Related]
3. Impact of capacity-limited binding on recombinant factor VIII and von Willebrand factor pharmacokinetics in hemophilia A rats.
Vargas Christensen I; Loftager M; Rode F; Mørck Nielsen H; Kreilgaard M; Larsen MS
J Thromb Haemost; 2019 Jun; 17(6):964-974. PubMed ID: 30924607
[TBL] [Abstract][Full Text] [Related]
4. BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice.
Seth Chhabra E; Liu T; Kulman J; Patarroyo-White S; Yang B; Lu Q; Drager D; Moore N; Liu J; Holthaus AM; Sommer JM; Ismail A; Rabinovich D; Liu Z; van der Flier A; Goodman A; Furcht C; Tie M; Carlage T; Mauldin R; Dobrowsky TM; Liu Z; Mercury O; Zhu L; Mei B; Schellenberger V; Jiang H; Pierce GF; Salas J; Peters R
Blood; 2020 Apr; 135(17):1484-1496. PubMed ID: 32078672
[TBL] [Abstract][Full Text] [Related]
5. Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII.
Demers M; Aleman MM; Kistanova E; Peters R; Salas J; Seth Chhabra E
J Thromb Haemost; 2022 Jul; 20(7):1674-1683. PubMed ID: 35466511
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
Kolind MP; Nørby PL; Berchtold MW; Johnsen LB
J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947
[TBL] [Abstract][Full Text] [Related]
7. Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States.
Neufeld EJ; Sidonio RF; O'Day K; Runken MC; Meyer K; Spears J
J Med Econ; 2018 Aug; 21(8):762-769. PubMed ID: 29681200
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
[TBL] [Abstract][Full Text] [Related]
9. Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
Zollner SB; Raquet E; Müller-Cohrs J; Metzner HJ; Weimer T; Pragst I; Dickneite G; Schulte S
Thromb Res; 2013 Aug; 132(2):280-7. PubMed ID: 23830969
[TBL] [Abstract][Full Text] [Related]
10. Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis.
Miners AH; Krishnan S; Pasi KJ
J Thromb Haemost; 2016 Nov; 14(11):2141-2147. PubMed ID: 27510890
[TBL] [Abstract][Full Text] [Related]
11. Expression of factor VIII in recombinant and transgenic systems.
Soukharev S; Hammond D; Ananyeva NM; Anderson JA; Hauser CA; Pipe S; Saenko EL
Blood Cells Mol Dis; 2002; 28(2):234-48. PubMed ID: 12064919
[TBL] [Abstract][Full Text] [Related]
12. Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences.
Chen CM; Wang CH; Wu SC; Lin CC; Lin SH; Cheng WT
Transgenic Res; 2002 Jun; 11(3):257-68. PubMed ID: 12113458
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protein unable to bind von Willebrand factor in recombinant factor VIII products.
Chun H; Pettersson JR; Shestopal SA; Wu WW; Marakasova ES; Olivares P; Surov SS; Ovanesov MV; Shen RF; Sarafanov AG
J Thromb Haemost; 2021 Apr; 19(4):954-966. PubMed ID: 33527662
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.
Casonato A; Pontara E; Zerbinati P; Zucchetto A; Girolami A
Am J Clin Pathol; 1998 Mar; 109(3):347-52. PubMed ID: 9495210
[TBL] [Abstract][Full Text] [Related]
15. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.
Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
J Thromb Haemost; 2018 Sep; 16(9):1779-1788. PubMed ID: 29981270
[TBL] [Abstract][Full Text] [Related]
17. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Pipe SW; Montgomery RR; Pratt KP; Lenting PJ; Lillicrap D
Blood; 2016 Oct; 128(16):2007-2016. PubMed ID: 27587878
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
[TBL] [Abstract][Full Text] [Related]
19. High-affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats.
Øie CI; Roepstorff K; Behrens C; Bøggild Kristensen J; Karpf DM; Bolt G; Gudme CN; Kjalke M; Smedsrød B; Appa RS
J Thromb Haemost; 2016 Sep; 14(9):1803-13. PubMed ID: 27378673
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.
Fuller JR; Knockenhauer KE; Leksa NC; Peters RT; Batchelor JD
Blood; 2021 May; 137(21):2970-2980. PubMed ID: 33569592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
